Back to Search
Start Over
The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
- Source :
-
Bone [Bone] 2011 Dec; Vol. 49 (6), pp. 1290-8. Date of Electronic Publication: 2011 Sep 09. - Publication Year :
- 2011
-
Abstract
- Background: The mechanism for the uncoupling effects of Sr on bone remains to be evaluated. Osteoblasts play important roles in osteoclastogenesis through regulating receptor activated nuclear factor kappa B (RANK) ligand (RANKL) and osteoprotegerin (OPG) expression. We hypothesize that OPG plays an important role in the cross-talk between osteoclasts and osteoblasts in response to Sr treatment.<br />Materials and Methods: MC3T3E1 cells were treated with Sr chloride (0-3 mM) and conditioned media were collected at 24h after the treatment. The effect of conditioned media on osteoclastogenesis was evaluated by tartrate-resistant acid phosphatase (TRAP) staining and bone resorption pits analysis. OPG and RANKL mRNA expressions in osteoblastic cells and protein secretion in the conditioned media were analyzed with real-time PCR and ELISA assay, respectively. The role of OPG in Sr-mediated inhibition of osteoclastogenesis was further evaluated with anti-OPG antibody in pre-osteoclastic cells. The role of OPG in Sr-mediated uncoupling effects on osteoporotic bone was evaluated by an animal study. Ovariectomized rats were oral administrated with vehicle or Sr chloride for two months supplemented with anti-IgG antibody (control) or anti-OPG antibody. The effects of OPG neutralization after Sr treatment on bone metabolism were analyzed by microCT, bone histomorphometry and biochemical analysis.<br />Results: The conditioned media derived from Sr-treated osteoblastic cells exerted a dose-dependent inhibitory effect on osteoclastic differentiation and resorptive activity in pre-osteoclastic cells. OPG mRNA expression and protein secretion in osteoblastic cells were significantly increased after Sr treatment. Neutralization with anti-OPG antibody abolished the inhibitory effect of conditioned media on RANKL-induced osteoclastogenesis. The uncoupling effects of Sr treatment on trabecular bone were evidenced by greater bone volume and trabecular number, greater osteoid surface and bone formation rate, while less osteoclast surface. These effects were attenuated by the OPG neutralization by anti-OPG antibody injection.<br />Conclusion: The evidences from the in vitro and in vivo studies suggested that OPG played an important role in the uncoupling effect of Sr on bone metabolism, possibly by acting as a cross-talk molecule between osteoclasts and osteoblasts in response to Sr treatment.<br /> (Copyright © 2011 Elsevier Inc. All rights reserved.)
- Subjects :
- Anabolic Agents pharmacology
Animals
Antibodies, Neutralizing pharmacology
Bone Resorption drug therapy
Bone Resorption genetics
Bone Resorption pathology
Cell Differentiation drug effects
Cell Line
Culture Media, Conditioned pharmacology
Female
Gene Expression Regulation drug effects
Mice
Osteoblasts drug effects
Osteoclasts drug effects
Osteogenesis drug effects
Osteoprotegerin genetics
Ovariectomy
RANK Ligand genetics
RANK Ligand metabolism
RANK Ligand pharmacology
RNA, Messenger genetics
RNA, Messenger metabolism
Rats
Rats, Sprague-Dawley
Strontium therapeutic use
Tibia drug effects
Tibia pathology
Osteoblasts metabolism
Osteoblasts pathology
Osteoclasts metabolism
Osteoclasts pathology
Osteoprotegerin metabolism
Strontium pharmacology
Subjects
Details
- Language :
- English
- ISSN :
- 1873-2763
- Volume :
- 49
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- Bone
- Publication Type :
- Academic Journal
- Accession number :
- 21925296
- Full Text :
- https://doi.org/10.1016/j.bone.2011.08.031